Contineum Therapeutics, Inc.
Ticker: CTNM
| Insider | Title |
|---|---|
| Carmine N. Stengone | CEO and President, Director |
| Daniel S. Lorrain | Chief Scientific Officer |
| Evert B. Schimmelpennink | Director |
| John Stephen Healy | General Counsel and Corp Sec |
| Johnson Innovation - Jjdc, Inc. Johnson | 10% or greater ownership |
| Johnson Johnson | 10% or greater ownership |
| Lori Lyons-williams | Director |
| Olivia C Ware | Director |
| Peter T Slover | Chief Financial Officer |
| Sarah Boyce | Director |
| Side Fund Iv, L.p. Versant | 10% or greater ownership |
| Stephen L. Huhn | CMO Sr VP, Clinical Dev. |
| Todd R. Brady | Director |
| Troy A. Ignelzi | Director |
| Vantage I Gp, L.p. Versant | 10% or greater ownership |
| Vantage I Gp-gp, Llc Versant | 10% or greater ownership |
| Vantage I, L.p. Versant | 10% or greater ownership |
| Venture Capital Iv, L.p. Versant | 10% or greater ownership |
| Venture Capital Vi, L.p. Versant | 10% or greater ownership |
| Ventures Iv, Llc Versant | 10% or greater ownership |
| Ventures Vi Gp, L.p. Versant | 10% or greater ownership |
| Ventures Vi Gp-gp, Llc Versant | 10% or greater ownership |